Healey CS - Search Results

1

Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

Eng C, Foster KA, Healey CS, Houghton C, Gayther SA, Mulligan LM, Ponder BA. Eng C, et al. Among authors: healey cs. Br J Cancer. 1996 Aug;74(3):339-41. doi: 10.1038/bjc.1996.363. Br J Cancer. 1996. PMID: 8695346 Free PMC article.

2

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ, et al. Eng C, et al. Among authors: healey cs. Genes Chromosomes Cancer. 1995 Mar;12(3):209-12. doi: 10.1002/gcc.2870120308. Genes Chromosomes Cancer. 1995. PMID: 7536460

3

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA. Eng C, et al. Among authors: healey cs. Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x. Clin Endocrinol (Oxf). 1995. PMID: 7641404

4

Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.

Lorenzo MJ, Eng C, Mulligan LM, Stonehouse TJ, Healey CS, Ponder BA, Smith DP. Lorenzo MJ, et al. Among authors: healey cs. Oncogene. 1995 Apr 6;10(7):1377-83. Oncogene. 1995. PMID: 7731689

5

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.

Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD, Ponder BA. Eng C, et al. Among authors: healey cs. Oncogene. 1995 Feb 2;10(3):509-13. Oncogene. 1995. PMID: 7845675

6

Haplotype analysis of MEN 2 mutations.

Gardner E, Mulligan LM, Eng C, Healey CS, Kwok JB, Ponder MA, Ponder BA. Gardner E, et al. Among authors: healey cs. Hum Mol Genet. 1994 Oct;3(10):1771-4. doi: 10.1093/hmg/3.10.1771. Hum Mol Genet. 1994. PMID: 7849700

7

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JB, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, et al. Mulligan LM, et al. Among authors: healey cs. Nat Genet. 1994 Jan;6(1):70-4. doi: 10.1038/ng0194-70. Nat Genet. 1994. PMID: 7907913

8

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, et al. Eng C, et al. Among authors: healey cs. Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237. Hum Mol Genet. 1994. PMID: 7911697

9

Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.

McMahon R, Mulligan LM, Healey CS, Payne SJ, Ponder M, Ferguson-Smith MA, Barton DE, Ponder BA. McMahon R, et al. Among authors: healey cs. Hum Mol Genet. 1994 Apr;3(4):643-6. doi: 10.1093/hmg/3.4.643. Hum Mol Genet. 1994. PMID: 7915166

10

A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.

Mulligan LM, Eng C, Healey CS, Ponder MA, Feldman GL, Li P, Jackson CE, Ponder BA. Mulligan LM, et al. Among authors: healey cs. Hum Mol Genet. 1994 Jun;3(6):1007-8. doi: 10.1093/hmg/3.6.1007. Hum Mol Genet. 1994. PMID: 7951212 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page